HCP5 Promotes Proliferation and Contributes to Cisplatin Resistance in Gastric Cancer Through miR-519d/HMGA1 Axis

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.2144229313949
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Stessin AM, Sison C, Schwartz A, et al. Does adjuvant radiotherapy benefit patients with diffuse-type gastric cancer? Results from the surveillance, epidemiology, and end results database. Cancer. 2015;120(22):3562–3568. doi:10.1002/cncr.28913
   Web of Science ®Google Scholar
• Nakayama Y, Mimura K, Kua LF, et al. Immune suppression caused by PD-L2 expression on tumor cells in gastric cancer. Gastric Cancer. 2020;23:961–973. doi:10.1007/s10120-020-01079-z32367440
   PubMed Web of Science ®Google Scholar
• Sgambato D, Miranda A, Romano L, Romano M. Gut microbiota and gastric disease. Minerva Gastroenterol Dietol. 2017;63(4):345–354. doi:10.23736/S1121-421X.17.02380-728206729
   PubMed Web of Science ®Google Scholar
• Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol. 2013;26(2):155–165. doi:10.1038/modpathol.2012.16022996375
   PubMed Web of Science ®Google Scholar
• Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011;1(5):391. doi:10.1158/2159-8290.CD-11-020922096659
   PubMed Web of Science ®Google Scholar
• Qiu MT, Hu JW, Yin R, Xu L. Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol. 2013;34(2):613–620. doi:10.1007/s13277-013-0658-623359273
   PubMedGoogle Scholar
• Wang H, Guan Z, He K, Qian J, Cao J, Teng L. LncRNA UCA1 in anti-cancer drug resistance. Oncotarget. 2017;8(38):64638–64650. doi:10.18632/oncotarget.1834428969100
   PubMedGoogle Scholar
• Qu L, Ding J, Cheng C, et al. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 2016;29(5):653–668. doi:10.1016/j.ccell.2016.03.00427117758
   PubMed Web of Science ®Google Scholar
• Zhang Y, Song X, Wang X, Hu J, Jiang L. Silencing of LncRNA HULC enhances chemotherapy induced apoptosis in human gastric cancer. J Med Biochem. 2016;35(2):137–143. doi:10.1515/jomb-2015-001628356873
   PubMed Web of Science ®Google Scholar
• Wang L, Luan T, Zhou S, Lin J, Yang Y. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p. Cancer Med. 2019;8(4):4389–4403. doi:10.1002/cam4.233531215169
   PubMed Web of Science ®Google Scholar
• Chen R, Xin G, Zhang X. Long non-coding RNA HCP5 serves as a ceRNA sponging miR-17-5p and miR-27a/b to regulate the pathogenesis of childhood obesity via the MAPK signaling pathway. J Pediatr Endocrinol Metab. 2019;32(12).
   Web of Science ®Google Scholar
• Jiang L, Wang R, Fang L, Ge X, Chen L. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis. Theranostics. 2019;9(9):2460–2474. doi:10.7150/thno.3109731131047
   PubMed Web of Science ®Google Scholar
• Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–283. doi:10.1038/nrg.2016.2027040487
   PubMed Web of Science ®Google Scholar
• Ding X, Zheng Y, Wang Z, et al. Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer. Oncol Rep. 2018;39:3. doi:10.3892/or.2018.633529115542
   PubMed Web of Science ®Google Scholar
• Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287–314. doi:10.1146/annurev-pathol-012513-10471524079833
   PubMed Web of Science ®Google Scholar
• Yue H, Tang B, Zhao Y, et al. MIR-519d suppresses the gastric cancer epithelial-mesenchymal transition via Twist1 and inhibits Wnt/β-catenin signaling pathway. Am J Transl Res. 2017;9(8):3654–3664.28861156
   PubMed Web of Science ®Google Scholar
• Pang Y, Mao H, Shen L, Zhao Z, Liu R, Liu P. MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP. Onco Targets Ther. 2014;587. doi:10.2147/OTT.S6028924790458
   PubMed Web of Science ®Google Scholar
• Chen Y, Ren C, Yang L, et al. MicroRNA let‑7d‑5p rescues ovarian cancer cell apoptosis and restores chemosensitivity by regulating the p53 signaling pathway via HMGA1. Int J Oncol. 2019;54(5):1771–1784. doi:10.3892/ijo.2019.473130816441
   PubMed Web of Science ®Google Scholar
• Chen X, Liu M, Meng F, Sun B, Jin X, Jia C. The long noncoding RNA HIF1A-AS2 facilitates cisplatin resistance in bladder cancer. J Cell Biochem. 2019;120(1):243–252. doi:10.1002/jcb.2732730216500
   PubMed Web of Science ®Google Scholar
• Zhang W, Kong G, Zhang J, Wang T, Ye L, Zhang X. MicroRNA-520b inhibits growth of hepatoma cells by targeting MEKK2 and cyclin D1. PLoS One. 2012;7(2):e31450. doi:10.1371/journal.pone.003145022319632
   PubMed Web of Science ®Google Scholar
• Wang J, Xu W, He Y, et al. LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN[J]. Inflamm Res. 2018;67:927–936. doi:10.1007/s00011-018-1186-z30310931
   PubMed Web of Science ®Google Scholar
• Wu H, Liu B, Chen Z, Li G, Zhang Z. MSC-induced lncRNA HCP5 drove fatty acid oxidation through miR-3619-5p/AMPK/PGC1α/CEBPB axis to promote stemness and chemo-resistance of gastric cancer. Cell Death Dis. 2020;11(4):233. doi:10.1038/s41419-020-2426-z32300102
   PubMed Web of Science ®Google Scholar
• Wu J, Chen H, Ye M, et al. Downregulation of long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression. Biomed Pharmacother. 2019;115:108869. doi:10.1016/j.biopha.2019.10886931028999
   PubMed Web of Science ®Google Scholar
• Ma H, Wang J, Shi J, Zhang W, Zhou D. LncRNA LINC00467 contributes to osteosarcoma growth and metastasis through regulating HMGA1 by directly targeting miR-217. Eur Rev Med Pharmacol Sci. 2020;24(11):5933–5945. doi:10.26355/eurrev_202006_2148632572906
   PubMed Web of Science ®Google Scholar
• Wu Z, Wang W, Wang Y, et al. LINC00963Long noncoding RNA promotes breast cancer progression by functioning as a molecular sponge for microRNA-625 and thereby upregulating HMGA1. Cell Cycle. 2020;19(5):610–624. doi:10.1080/15384101.2020.172802432052688
   PubMed Web of Science ®Google Scholar
• Liu L, Zhang S, Hu L, Liu L, Guo W, Zhang J. HMGA1 participates in MHCC97H cell proliferation and invasion through the ILK/Akt/GSK3β signaling pathway. Mol Med Rep. 2017;16(6):9287–9294. doi:10.3892/mmr.2017.782029152644
   PubMed Web of Science ®Google Scholar
• Sekimoto N, Suzuki A, Suzuki Y, Sugano S. Expression of miR‑26a exhibits a negative correlation with HMGA1 and regulates cancer progression by targeting HMGA1 in lung adenocarcinoma cells. Mol Med Rep. 2017;15(2):534–542. doi:10.3892/mmr.2016.605328000891
   PubMed Web of Science ®Google Scholar